When you optimize clinical workflows for high-frequency procedures at your healthcare organization, you’re far more likely to realize significant returns on your investment. Whether it’s to support ...
OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
Abstract: https://www.acpjournals.org/doi/10.7326/M22-1079 Editorial: https://www.acpjournals.org/doi/10.7326/M22-2329 URLs go live when the embargo lifts The ...
Dr. Metcalf is Section Chief of Transfusion Medicine, Associate Professor of Pathology, and Inpatient Chief Value Officer for the Department of Pathology at the University of Utah Health and ARUP ...
Milwaukee--An exhaustive review and analysis of the medical literature by a panel of experts at the International Consensus Conference on Transfusion and Outcomes (ICCTO) held this month in Phoenix ...
Recent blood transfusion can cause an artificially low hemoglobin A1c (HbA1c). Options for follow-up include monitoring home blood sugar readings; checking a fructosamine (glycosylated albumin) level, ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Clinical Monitoring and Computing in which Dr. Ayten ...
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis through ex vivo clustered regularly interspaced short palindromic repeats (CRISPR)–Cas9 ...
To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results